Escape from the Matrix: Multiple Mechanisms for Fibroblast Activation in Pulmonary Fibrosis
- 15 April 2008
- journal article
- Published by American Thoracic Society in Proceedings of the American Thoracic Society
- Vol. 5 (3) , 311-315
- https://doi.org/10.1513/pats.200710-159DR
Abstract
Lung fibrosis is a recognized feature of many chronic lung diseases and is central to the pathogenesis of idiopathic pulmonary fibrosis, a disease that carries a prognosis worse than many cancers. Current research into this condition is defining the key pathways of activation either in resident fibroblasts, matrix-producing cells derived from circulating fibrocytes, or epithelial cells that appear to transdifferentiate to fibroblast-like cells. The downstream signaling pathways are also being delineated as well as the gene interactions leading to altered cell phenotype. These studies have led to an appreciation that multiple pathways, including inflammatory and coagulation cascades, are involved in the pathogenesis of idiopathic pulmonary fibrosis. As these facts come to light, we are exploring promising new approaches to treat fibroses and halt the inexorable progression that is a feature of these disorders. This article reviews these findings and our current concepts of the key molecular events leading to tissue damage and excessive matrix deposition in lung fibrosis. It also highlights the need for new studies to delineate alternative pathogenetic mechanisms and integrate these pathways so we have a framework to better understand their importance in individual patients.Keywords
This publication has 65 references indexed in Scilit:
- Mice Lacking Neutrophil Elastase Are Resistant to Bleomycin-Induced Pulmonary FibrosisThe American Journal of Pathology, 2007
- Circulating peripheral blood fibrocytes in human fibrotic interstitial lung diseaseBiochemical and Biophysical Research Communications, 2006
- Fibroblasts and myofibroblasts: Their source, function and role in diseasePublished by Elsevier ,2006
- Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrixProceedings of the National Academy of Sciences, 2006
- Transgenic Modeling of Transforming Growth Factor- 1: Role of Apoptosis in Fibrosis and Alveolar RemodelingProceedings of the American Thoracic Society, 2006
- Evolving Concepts of Apoptosis in Idiopathic Pulmonary FibrosisProceedings of the American Thoracic Society, 2006
- Ligation of protease-activated receptor 1 enhances v 6 integrin-dependent TGF- activation and promotes acute lung injuryJournal of Clinical Investigation, 2006
- Direct Thrombin Inhibition Reduces Lung Collagen, Accumulation, and Connective Tissue Growth Factor mRNA Levels in Bleomycin-Induced Pulmonary FibrosisThe American Journal of Pathology, 2001
- A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 1999
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992